Screening Brief Intervention Referral to Treatment (SBIRT) in New Mexico
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01131520 |
Recruitment Status
:
Completed
First Posted
: May 27, 2010
Results First Posted
: August 21, 2017
Last Update Posted
: December 12, 2017
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Drug Abuse HIV Risk Behavior | Behavioral: Computerized brief intervention Behavioral: Counselor delivered brief intervention | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 360 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | SBIRT in New Mexico |
Study Start Date : | June 2010 |
Actual Primary Completion Date : | December 2012 |
Actual Study Completion Date : | July 2015 |
Arm | Intervention/treatment |
---|---|
Experimental: Computerized Brief Intervention
Computerized one-session brief intervention for drug use
|
Behavioral: Computerized brief intervention
This is a brief computerized intervention focused on drug use of patients receiving primary care treatment in an outpatient setting. The intervention is delivered in one session.
|
Active Comparator: Counselor delivered brief intervention
This is a brief intervention focused on drug use delivered by a behavioral health counselor and based on motivational interviewing
|
Behavioral: Counselor delivered brief intervention
This is a one session brief intervention delivered in a primary care setting that is based on motivational interviewing.
|
- Alcohol, Smoking & Substance Involvement Screening Test (ASSIST) Score [ Time Frame: 3 months post-baseline ]The ASSIST's Global Continuum of Illicit Drug Risk was used. A higher score is considered more severe risk. The scores range from 0 to 308.
- Hair Testing [ Time Frame: 3 month post-baseline ]The number of participants testing positive on Radioimmunoassay (RIA) Hair Testing for opiates, cocaine, amphetamine and tetrahydrocannabinol (THC)
- Human Immunodeficiency Virus (HIV) Drug Use Risk Assessment Battery Subscale [ Time Frame: 3 months post-baseline ]HIV Drug Use Risk Assessment Battery Subscale Score ranges from 0 to 22. A higher score is considered to be associated with higher risk.
- Alcohol, Smoking & Substance Involvement Screening Test (ASSIST) Score [ Time Frame: 6 month post-baseline ]ASSIST's Global Continuum of Illicit Drug Risk Score which ranges from 0 to 308. A higher score is associated with higher risk.
- Alcohol, Smoking & Substance Involvement Screening Test (ASSIST) Score [ Time Frame: 12 months post-baseline ]ASSIST's Global Continuum of Illicit Drug Risk Score which ranges from 0 to 308. A higher score is associated with higher risk.
- Hair Testing [ Time Frame: 6 month post-baseline ]The predicted probabilities for testing positive on Radioimmunoassay (RIA) Hair Testing for opiates, cocaine, amphetamine and tetrahydrocannabinol (THC), calculated from generalized estimating equations.
- Hair Testing [ Time Frame: 12 month post-baseline ]Predicted Probabilities for testing positive on the Radioimmunoassay (RIA) Hair Testing for opiates, cocaine, amphetamine and THC, calculated from generalized estimating equations.
- Human Immunodeficiency Virus (HIV) Risk Assessment Battery Subscale [ Time Frame: 6 month post-baseline ]HIV Drug Use Risk Assessment Battery Subscale Score ranges from 0 to 22. A higher score is considered to be associated with higher risk.
- Human Immunodeficiency Virus (HIV) Risk Assessment Battery Subscale Score [ Time Frame: 12 month post-baseline ]HIV Drug Use Risk Assessment Battery Subscale Score ranges from 0 to 22. A higher score is considered to be associated with higher risk.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- 18 years or older
- Moderate risk category on the ASSIST scores
Exclusion Criteria:
- planning to move out of New Mexico in the next year
- receipt of formal drug abuse treatment or a brief intervention for drug use in the past month.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01131520
United States, Maryland | |
Friends Research Institute | |
Baltimore, Maryland, United States, 21201 |
Principal Investigator: | Robert P Schwartz, M.D. | Friends Research Institute, Inc. |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: | Friends Research Institute, Inc. |
ClinicalTrials.gov Identifier: | NCT01131520 History of Changes |
Other Study ID Numbers: |
08-08-173 R01DA026003 ( U.S. NIH Grant/Contract ) |
First Posted: | May 27, 2010 Key Record Dates |
Results First Posted: | August 21, 2017 |
Last Update Posted: | December 12, 2017 |
Last Verified: | November 2017 |
Keywords provided by Friends Research Institute, Inc.:
SBIRT Drug abuse |
Additional relevant MeSH terms:
Substance-Related Disorders Chemically-Induced Disorders Mental Disorders |